CanaQuest Investor Presentation Q1 2023

A Clinical Stage/Life Sciences company focussed on the drug discovery and development of next generation targeted therapeutics within the endocannabinoid system and specific brain receptors. Partnered for industry research and product development with Dr. Steven Laviolette, a professor and neuroscientist, with decades of experience in the field of mental health and cannabinoids, at Western University.